Rockefeller Capital Management
TNGX icon

Rockefeller Capital Management’s Tango Therapeutics TNGX Stock Holding History

Rockefeller Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$760K Buy
36,340
+35,453
+3,997% +$493K ﹤0.01% 1748
2025
Q4 		$7.86K Buy
887
+765
+627% +$6.59K ﹤0.01% 3914
2025
Q3 		$1.02K Buy
+122
New +$826 ﹤0.01% 4186

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Rockefeller Capital Management's TNGX Position: Q1 2026 in Review

Rockefeller Capital Management increased its Tango Therapeutics (TNGX) stake by 3,997% in Q1 2026, buying an estimated $493K and bringing the position to 36,340 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

Rockefeller Capital Management first reported a position in TNGX in Q3 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Rockefeller Capital Management held 36,340 shares of Tango Therapeutics worth $760K as of Q1 2026.
  • Rockefeller Capital Management bought 35,453 Tango Therapeutics shares in Q1 2026, an estimated $493K.
  • Tango Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1748 holding.
  • Rockefeller Capital Management first reported a position in Tango Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.